hydroxychloroquine

Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of the drug hydroxychloroquine makes hospitalized patients substantially less likely to die.The study, published in the International Journal of Infectious Diseases, determined that hydroxychloroquine provided a "66% hazard ratio reduction," and hydroxychloroquine and azithromycin a 71 percent reduction, compared to neither treatment.In-hospital mortality was…

A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.The study analyzed 2,541 patients hospitalized among the system’s six hospitals…

HuffPost is part of Verizon Media. Click 'I agree' to allow Verizon Media and our partners to use cookies and similar technologies to access your device and use your data (including location) to understand your interests, and provide and measure personalised ads. We will also provide you with personalised ads on partner products. Learn more…

Ditched drug — All the data is pointing to the popular anti-malaria drug having no effect. Beth Mole - Jun 17, 2020 10:45 pm UTC Enlarge / Pills of Hydroxychloroquine sit on a tray at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. The World Health Organization on Wednesday announced that it is…

CoronavirusNOW: Live updates on the COVID-19 pandemicSpecial coverage of the COVID-19 public health crisis, including breaking news from around the country, exclusive interviews with health officials and live content from a variety of public health resources and press conferences. Produced by FOX Television Stations, this stream includes content from local FOX affiliates, FOX News, FOX…